Anti-GCLC antibody [EPR20078]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(22 Publications)
Rabbit Recombinant Monoclonal GCLC antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 22 publications.
View Alternative Names
GLCL, GLCLC, GCLC, Glutamate--cysteine ligase catalytic subunit, GCS heavy chain, Gamma-ECS, Gamma-glutamylcysteine synthetase
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-GCLC antibody [EPR20078] (AB207777)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling GCLC with ab207777 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining on HepG2 cell line. The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-GCLC antibody [EPR20078] (AB207777)
GCLC was immunoprecipitated from 0.35 mg of HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab207777 at 1/40 dilution.
Western blot was performed from the immunoprecipitate using ab207777 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HepG2 whole cell lysate 10μg (Input).
Lane 2 : ab207777 IP in HepG2 whole cell lysate.
Lane 3 : Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab207777 in HepG2 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-GCLC antibody [EPR20078] (ab207777)
Predicted band size: 73 kDa
false
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-GCLC antibody [EPR20078] (AB207777)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed PC-12 (Rat adrenal gland pheochromocytoma cell line) cells labeling GCLCwith ab207777 at 1/60 dilution (red) compared with aRabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-GCLC antibody [EPR20078] (AB207777)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized PC-12 (Rat adrenal gland pheochromocytoma cell line) cells labeling GCLC with ab207777 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining on PC-12 cell line. The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.
- WB
Supplier Data
Western blot - Anti-GCLC antibody [EPR20078] (AB207777)
Blocking/Dilution buffer : 5% NFDM/TBST.
Lanes 1 - 2:
Western blot - Anti-GCLC antibody [EPR20078] (ab207777) at 1/2000 dilution
Lanes 3 - 5:
Western blot - Anti-GCLC antibody [EPR20078] (ab207777) at 1/1000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 10 µg
Lane 4:
Human lung lysate at 10 µg
Lane 5:
Human fetal liver lysate at 10 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 4 - 5:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 73 kDa
Observed band size: 73 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-GCLC antibody [EPR20078] (AB207777)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1-3 : 3 minutes; Lane 4 : 15 seconds; Lane 5 : 3 seconds; Lane 6 : 5 seconds.
Lanes 1 - 2:
Western blot - Anti-GCLC antibody [EPR20078] (ab207777) at 1/2000 dilution
Lanes 3 - 6:
Western blot - Anti-GCLC antibody [EPR20078] (ab207777) at 1/1000 dilution
Lane 1:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 3:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 4:
Rat liver lysate at 10 µg
Lane 5:
Mouse liver lysate at 10 µg
Lane 6:
Mouse spleen lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 73 kDa
Observed band size: 73 kDa
false
Related conjugates and formulations (1)
-
Anti-GCLC antibody [EPR20078] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:18460 PubMed40425777
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 12:1578755 PubMed40421419
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1569888 PubMed40308754
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed40178905
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1508047 PubMed40110131
2025
Applications
Unspecified application
Species
Unspecified reactive species
AMB Express 14:100 PubMed39251509
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23808 PubMed39132830
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurochemical research 49:2910-2925 PubMed39060766
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 181:2545-2565 PubMed38599607
2024
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 13: PubMed38397767
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com